 BOSTON, Nov. 16, 2020 PRNewswire -- Proteostasis Therapeutics, Inc. Nasdaq:PTI, a clinical stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2020. In August 2020, Proteostasis and Yumanity Therapeutics, Inc. Yumanity,... 